A Randomized Phase III Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 21 Jul 2017
At a glance
- Drugs Enoxaparin sodium (Primary) ; Carboplatin; Cisplatin; Etoposide
- Indications Small cell lung cancer
- Focus Therapeutic Use
- Acronyms RASTEN
- 21 Jul 2017 Trial has been completed in Sweden (end date: 2017-05-05).
- 13 Sep 2016 Planned End Date changed from 1 Apr 2017 to 1 Jun 2017.
- 13 Sep 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Jun 2017.